IMPORTANT WARNING:
Daunorubicin lipid complex injection must be given under the supervision of a doctor who is experienced in giving chemotherapy medications for cancer.
Daunorubicin lipid complex may cause serious or life-threatening heart problems at any time during your treatment or months to years after your treatment has ended. Your doctor will order tests before and during your treatment to see if your heart is working well enough for you to safely receive daunorubicin lipid complex. These tests may include an electrocardiogram (ECG; test that records the electrical activity of the heart) and an echocardiogram (test that uses sound waves to measure your heart's ability to pump blood). Your doctor may tell you that you should not receive this medication if the tests show your heart's ability to pump blood has decreased. Tell your doctor if you have or have ever had any type of heart disease or radiation (x-ray) therapy to the chest area. Tell your doctor and pharmacist if you are taking or have ever received certain cancer chemotherapy medications such as doxorubicin (Doxil), epirubicin (Ellence), idarubicin (Idamycin), mitoxantrone (Novantrone), cyclophosphamide (Cytoxan), or trastuzumab (Herceptin). If you experience any of the following symptoms, call your doctor immediately: shortness of breath; difficulty breathing; swelling of the hands, feet, ankles or lower legs; or fast, irregular, or pounding heartbeat.
Daunorubicin lipid complex can cause a severe decrease in the number of blood cells in your bone marrow. This may cause certain symptoms and may increase the risk that you will develop a serious infection. If you experience any of the following symptoms, call your doctor immediately: fever, chills, sore throat, ongoing cough and congestion, or other signs of infection.
Tell your doctor if you have or have ever had liver disease. Your doctor may need to adjust your dose if you have liver disease.
You may experience a reaction while you receive a dose of daunorubicin lipid complex injection, usually within 5 minutes after your infusion starts. Tell your doctor immediately if you experience any of these symptoms while you receive daunorubicin lipid complex: back pain, flushing, and chest tightness.
Keep all appointments with your doctor and the laboratory. Your doctor will order certain tests to check your body's response to daunorubicin lipid complex.